The dynamic mass spectrometry probe (DMSP) - Advanced process analytics for therapeutic cell manufacturing, health monitoring and biomarker discovery

Spatially and temporally resolved in situ monitoring of biochemical cell culture environments, e.g., in application to therapeutic cell bioreactors, is of critical importance for facilitating the development of new and reliable quality control methodologies for cell therapies. Identifying and monitoring secreted biomolecular critical quality attributes (CQAs) to enable online feedback control will enable large scale, cost-effective manufacturing of therapeutic cells. These CQA biomarkers have varying concentrations within a bioreactor, both in time and space. Current methods for monitoring these diverse biomolecules are generally ex-situ, time consuming, destructive, provide bulk measurements, or lack the ability to reveal the complete secretome/metabolome composition. The Dynamic Mass Spectrometry Probe (DMSP) synergistically incorporates a sampling interface for localized intake of a small fluid volume of the cellular content, a micro-fabricated mass exchanger for sample conditioning and inline separation, and an integrated electrospray ionization (ESI) emitter for softly ionizing (i.e. preserved biochemical structure) extracted biomolecules for mass spectrometry (MS). ESI-MS via DMSP treatment enables both biomarker discovery and transient (~1 min) analysis of biochemical information indicative of cell health and potency. DMSP is manufactured using advanced batch microfabrication techniques, which minimize dead volume (~20 nL) and ensure repeatable operation and precise geometry of each device. DMSP treatment removes 99% of compounds that interfere with mass spectrometry analysis, such as inorganic salts, while retaining biomolecules of interest within the sample for ESI-MS analysis. DMSP has demonstrated the ability to substantially increase signal to noise ratio in MS detection of biomolecules, and to further enhance sensitivity for probing lower biomarker concentrations via introduction of ESI-MS enhancing molecules (i.e. proton donating chemicals, protein denaturing solvents, and supercharging agents) into the sample within the integrated mass exchanger. To exemplify the DMSP’s unique capabilities, Fig. 1 demonstrates detection of multiple low-concentration protein biomarkers sampled from a biochemically-complex cell media solution serving as a proxy to samples taken directly from cell growth bioreactors [1]. Please click Additional Files below to see the full abstract

The Dynamic Sampling Platform (DSP) for Real-time Bioreactor Monitoring

Biomanufacturing for advanced therapies depends on the reliable and reproducible growth of cells. Cells continuously secrete biomolecules that serve as the critical quality attributes (CQAs) for manufacturing, but current sensor technologies are incapable of characterizing these biomarkers in real-time. The Dynamic Sampling Platform (DSP) is a technology for real-time analysis of the chemical content of bioreactors. It synergistically combines aseptic, spatially resolved, direct-from-reactor sampling with inline sample treatment and rapid electrospray ionization mass spectrometry (ESI-MS) sensing to fill the void of existing process analytical technologies for real-time CQA monitoring in biomanufacturing. DSP samples non-invasively from near where cells are growing to capture the rich microenvironment, with high relative concentrations of biomarkers, and subsequently treats these samples for real-time electrospray ionization mass spectrometry (ESI-MS) analysis. ESI-MS is a powerful analytical technology for the detection of biomolecules, but it is hindered by a need for extensive sample treatment which has made the technique largely an offline approach. The DSP utilizes a novel “active sample treatment†to prepare complex biochemical samples for ESI-MS by conditioning the sample via selective salt removal, MS enhancing chemical infusion, and biomolecule retention. The DSP is produced by employing advanced microfabrication techniques. The final device utilizes a micro-mass exchanger which replaces time consuming sample preparation steps with a ~1 second flow through reactor. The results of this dissertation demonstrate the DSP's utility to help unlock the potential of advanced therapeutic cell manufacturing by providing detailed biochemical information about the process for closed feedback control of bioreactors, allowing for nascent therapies to reach a broad patient population.Ph.D

The nine C-terminal amino acids of the respiratory syncytial virus protein P are necessary and sufficient for binding to ribonucleoprotein complexes in which six ribonucleotides are contacted per N protein protomer.

The respiratory syncytial virus (RSV) phosphoprotein (P) is a major polymerase co-factor that interacts with both the large polymerase fragment (L) and the nucleoprotein (N). The N-binding domain of RSV P has been investigated by co-expression of RSV P and N proteins in Escherichia coli. Pull-down assays performed with a series of truncated forms of P fused to glutathione S-transferase (GST) revealed that the region comprising the last nine C-terminal amino acid residues of P (233-DNDLSLEDF-241) is sufficient for efficient binding to N. Site-directed mutagenesis shows that the last four residues of this peptide are crucial for binding and must be present at the end of a flexible C-terminal tail. The presence of the P oligomerization domain (residues 100-160) was an important stabilizing factor for the interaction. The tetrameric full-length P fused to GST was able to pull down both helical and ring structures, whereas a monomeric C-terminal fragment of P (residues 161-241) fused to GST pulled down exclusively RNA-N rings. Electron-microscopy analysis of the purified rings showed the presence of two types of complex: undecamers (11N) and decamers (10N). Mass-spectrometry analysis of the RNA extracted from rings after RNase A treatment showed two peaks of 22,900 and 24,820 Da, corresponding to a mean RNA length of 67 and 73 bases, respectively. These results suggest strongly that each N subunit contacts 6 nt, with an extra three or four bases further protected from nuclease digestion by the ring structure at both the 5' and 3' ends